HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tom G Caniels Selected Research

COVA1-18

10/2021COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tom G Caniels Research Topics

Disease

14COVID-19
01/2022 - 01/2020
3Infections
01/2022 - 01/2021
1Human Influenza (Influenza)
01/2022
1Lymphopenia (Lymphocytopenia)
10/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Thrombosis (Thrombus)
01/2021
1Inflammation (Inflammations)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Critical Illness (Critically Ill)
01/2021

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
01/2022 - 01/2020
6AntibodiesIBA
11/2021 - 01/2020
5Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2020
4Neutralizing AntibodiesIBA
01/2022 - 01/2020
2BNT162 VaccineIBA
01/2022 - 01/2021
1mRNA VaccinesIBA
01/2022
1Hemagglutinins (Hemagglutinin)IBA
01/2022
1COVA1-18IBA
10/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1NanovaccinesIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2020